PCYC

Pharmacyclics, Inc. News Headlines

$85.61
*  
0.01
  negative  
0.01%
Get PCYC Alerts
*Delayed - data as of May 24, 2013 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

FDA Designation for Synageva Candidate - Analyst Blog
5/22/2013 4:27:38 PM - Zacks.com

2013 FDA Drug Approval Calendar
5/21/2013 7:00:00 AM - TheStreet

10 ASCO '13 Abstracts You Can Read Right Now
5/15/2013 6:00:00 PM - TheStreet

3 Biotech Stocks Spiking With Big Volume
5/13/2013 2:47:00 PM - TheStreet

Futures Weaker in Premarket Ahead of April Retail Sales Report
5/13/2013 8:12:00 AM - Knobias

6 Superstars For Your Biotech Portfolio: John McCamant
5/10/2013 2:57:00 PM - Seeking Alpha

Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy
5/9/2013 12:55:48 PM - David Moenning

Recent Noteworthy Institutional 5% Ownership Filings In Healthcare Sector
5/9/2013 3:46:00 AM - Seeking Alpha

Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers
5/7/2013 3:38:00 PM - Seeking Alpha

Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy
5/7/2013 1:53:41 PM - David Moenning

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
5/3/2013 10:18:00 PM - Seeking Alpha

Wider-Than-Expected Loss at Pharmacyclics - Analyst Blog
5/2/2013 2:26:47 PM - Zacks.com

PHARMACYCLICS Q1 13 Earnings Conference Call At 4:30 PM ET
5/1/2013 3:03:00 PM - RTT News

After-Hours Earnings Report for May 1, 2013 : LVS, MET, CBS, ADM, STX, MAC, FRT, UNM, FNF, PCYC, TEG, CVI
5/1/2013 2:00:04 PM - NASDAQ.com News

Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick
4/26/2013 3:20:21 PM - David Moenning

FDA Designation for Merck Candidate - Analyst Blog
4/25/2013 5:10:33 PM - Zacks.com

UPDATE: FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/24/2013 10:10:00 AM - Dow Jones Business News

FDA Gives 'Breakthrough' Designation to Merck Skin-Cancer Drug
4/23/2013 9:15:00 PM - Dow Jones Business News

Abbott - Epizyme Collaborate - Analyst Blog
4/23/2013 6:10:27 PM - Zacks.com

Best Stocks: Biotech Still Holding Top Spots
4/22/2013 10:00:00 AM - Minyanville

Biotech Stocks Get A Turbo Boost From Vertex
4/20/2013 9:33:00 AM - Seeking Alpha

PCYC Completes RESONATE Enrollment - Analyst Blog
4/19/2013 3:30:01 PM - Zacks.com

Pharmacyclics Earns 4th Milestone - Analyst Blog
4/15/2013 1:11:40 PM - Zacks.com

Pharmacyclics Gets Fourth $50 Million Milestone Payment from Janssen
4/11/2013 7:03:00 AM - Dow Jones Business News

Positive Data on PCYC's Ibrutinib - Analyst Blog
4/10/2013 5:09:09 PM - Zacks.com